Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
PHARMA MAR S A	28770 MADRID

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....

• 2006 Application Filing Year
• A61K Class
• 9598 Applications Filed
• 4848 Patents Issued To-Date
• 50.52 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Calvo, Salve Pilar	Madrid, ES	3	168
# of filed Patents : 3 Total Citations : 168
Tobio, Barreira Maria	Madrid, ES	1	7
# of filed Patents : 1 Total Citations : 7

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 4 Citation Count
• A61K Class

• 31.06 % this patent is cited more than
• 10 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	May 24, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
November 24, 2015	US,9192568,B2   US9192568B2	GRANTED PATENT AS SECOND PUBLICATION
March 19, 2009	US,20090076016,A1   US20090076016A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9192568

Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases

---

Abstract

---

Jorumycin, renieramycin, safracin and saframycin related compounds formulations, methods of preparing the same, articles of manufacture and kits with such formulations, and methods of treating proliferative diseases with the same formulations are provided.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• LAPS2019
• STCH2019
• FP2019
• FEPP2019
• I2015
• STCF2015
• P2009
• AS2008
• F2006
• PD2005

Date	Code	Event	Description
Dec 30, 2019	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES	free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY
Dec 30, 2019	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Nov 24, 2019	FP	LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Nov 24, 2019
Jul 15, 2019	FEPP	FEE PAYMENT PROCEDURE	free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY
Nov 24, 2015	I	Issuance
Nov 04, 2015	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Mar 19, 2009	P	Published
Jun 03, 2008	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CALVO SALVE, PILAR;TOBIO BARREIRA, MARIA;REEL/FRAME:021044/0747 Owner name: PHARMA MAR, S.A., SPAIN Effective Date: Jun 03, 2008
Oct 30, 2006	F	Filing
Oct 31, 2005	PD	Priority Date